Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Mark Brunner, M.D.

Concepts (323)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Andrew Brunner's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andrew Brunner has written about over time.
SEER Program, 7 publications between 2013 and 2022, average publication date August 2016. Hematologic Neoplasms, 4 publications between 2013 and 2021, average publication date January 2017. Isocitrate Dehydrogenase, 5 publications between 2014 and 2023, average publication date October 2017. Azepines, 2 publications between 2016 and 2019, average publication date June 2018. Remission Induction, 15 publications between 2014 and 2022, average publication date February 2019. fms-Like Tyrosine Kinase 3, 4 publications between 2016 and 2022, average publication date July 2019. Mutation, 17 publications between 2014 and 2024, average publication date August 2019. Hematopoietic Stem Cell Transplantation, 18 publications between 2013 and 2023, average publication date September 2019. Leukemia, Myeloid, Acute, 59 publications between 2013 and 2024, average publication date October 2019. Antineoplastic Combined Chemotherapy Protocols, 16 publications between 2016 and 2024, average publication date January 2020. Bone Marrow, 6 publications between 2016 and 2023, average publication date May 2020. Myeloproliferative Disorders, 4 publications between 2015 and 2022, average publication date June 2020. Immunoconjugates, 2 publications between 2019 and 2022, average publication date June 2021. Myelodysplastic Syndromes, 33 publications between 2015 and 2024, average publication date July 2021. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 10 publications between 2017 and 2024, average publication date December 2021. Azacitidine, 5 publications between 2022 and 2023, average publication date December 2022. Leukemia, Myelomonocytic, Chronic, 2 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Brunner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (323)
Explore
_
Co-Authors (133)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.